Original language | German |
---|---|
Pages (from-to) | 727-735 |
Journal | PNEUMOLOGIE |
Volume | 64 |
Issue number | 12 |
DOIs | |
Publication status | Published - 2010 |
[Current status of erlotinib and gefitinib in palliative therapy for NSCLC--does the EGF-R mutation state have any significance?].
Wolfgang Brückl* (First author), G H Wiest, Joachim H. Ficker (Last author)
*Corresponding author for this work
Research output: Contribution to journal › Review article › peer-review